Main Sequence Ventures

Main Sequence Ventures, founded in 2017 and backed by Australia's national science agency CSIRO, is a venture capital firm that focuses on deep tech and frontier technologies. The firm is headquartered in Australia and aims to solve significant global challenges through its investments. Main Sequence has a unique "venture science" model, which starts by identifying big challenges and bringing together science, people, and investment to create and fund companies that can address these issues. Main Sequence Ventures has built a strong portfolio with notable companies such as Q-CTRL, which makes quantum technology useful; Gilmour Space, which focuses on efficient satellite launches; and Emesent, a leader in robotics and autonomy technology. Other significant investments include Myriota, which provides low-cost satellite connectivity, and V2food, which develops sustainable meat alternatives. The firm's second fund, which raised $250 million, focuses on areas such as decarbonization, healthcare, and space technology. This fund supports companies like Kasada, a cybersecurity firm stopping bot attacks, and RapidAIM, which offers biosecurity solutions for pest management. Main Sequence Ventures is dedicated to leveraging scientific discoveries to create impactful, high-growth companies that can address some of the world's most pressing challenges. Their strategic investment approach and strong support for portfolio companies highlight their commitment to driving innovation and technological advancement globally.